Full Length Research Paper
References
|
Addo J, Ayerbe L, Mohan KM, Crichton S, Sheldenkar A, Chen R, Wolfe CD, McKevitt C (2012). Socioeconomic status and stroke: An updated review. Stroke 43(4):1186-91 Crossref |
||||
|
Anand K, Chowdhury D, Singh KB, Pandav CS, Kapoor SK (2001). Estimation of mortality and morbidity due to strokes in India. Neuroepidemiology 20(3):208-11. Crossref |
||||
|
Bonita R (1992). Epidemiology of stroke. Lancet 339(8789):342-4. Crossref |
||||
| Boutayeb A, Derouich M, Boutayeb W, Lamlili MEN (2014). Cerebrovascular Diseases and Associated Risk Factors in WHO Eastern Mediterranean Countries, Cardiology and Angiology. An. Inter. J. 2(1):62-75. | ||||
|
Connor M, Walker R, Modi G, Warlow C (2007). The burden of stroke in black populations in sub-Saharan Africa. The Lancet Neurol. 6(3):269-78. Crossref |
||||
|
Cox AM, McKevitt C, Rudd AG, Wolfe CDA (2006). Socioeconomic status and stroke. The Lancet Neurol. 5(2):181-8. Crossref |
||||
|
Donnan GA, McNeil JJ, Adena MA, Doyle AE, O'Malley HM, Neill GC(1989). Smoking as a risk factor for cerebral ischaemia. Lancet 2(8664):643-7. Crossref |
||||
|
Engels T, Baglione Q, Audibert M, Viallefont A, Mourji F, El Alaoui Faris M (2014). Socioeconomic Status and Stroke Prevalence in Morocco: Results from the Rabat-Casablanca Study. PLoS ONE 9(2):e89271. Crossref |
||||
|
Feigin VL, Lawes CM, Bennett DA, Anderson CS (2003). Stroke epidemiology: a review of population-based studies of incidence, prevalence, and case-fatality in the late 20th century. The Lancet Neurol. 2:43-53. Crossref |
||||
|
Feigin VL, Lawes CM, Bennett DA, Barker-Collo SL, Parag V (2009). Worldwide stroke incidence and early case fatality reported in 56 population-based studies: A systematic review. The Lancet Neurol. 8(4):355-69. Crossref |
||||
|
Forouhi NG, Sattar N (2006). CVD risk factors and ethnicity-a homogeneous relationship. Atheroscler. Suppl. 7(1):11-9. Crossref |
||||
| Fuster V, Kelly BB (2010). Promoting Cardiovascular Health in the Developing World. A critical Challenge to Achieve Global Health. The National Academies Press, Washington, D.C Available at: http://www.ncbi.nlm.nih.gov/ books/NBK45693/ pdf/ TOC.pdf. | ||||
|
Gaziano TA (2008). Economic burden and the cost-effectiveness of treatment of cardiovascular diseases in Africa. Heart 94(2):140-4. Crossref |
||||
| Gurubacharya DL, Lohani R, Rauniyar A (2006). Serum Urea, Creatinine and Electrolyte Status in Patients Presenting with Acute Gastroenteritis. J. Nepal Med. Assoc. 45:291-4. | ||||
|
Johnston SC, Mendis S, Mathers CD (2009). Global variation in stroke burden and mortality: Estimates from monitoring, surveillance, and modelling. The Lancet Neurol. 8:345-54. Crossref |
||||
|
Kaplan GA, Keil JE (1993). Socioeconomic factors and cardiovascular disease: a review of the literature. Circulation 88:1973-98. Crossref |
||||
| Kusuda K, Saku Y, Sadoshima S, Kozo I, Fujishima M (1989). Disturbances of fluid and electrolyte balance in patients with acute stroke. Nihon Ronen Igakkai Zasshi 26(3):223-7. | ||||
| Laloux P, Galanti L, Jamart J (2004). Lipids in ischemic stroke subtypes. Acta neurol. Belg. 104:13-19 | ||||
| Laurence EC, Lombard L, Volmink J (2011). Risk factors for myocardial infarction and stroke in Africa. SA Heart J. 8:12-23 | ||||
| Longo-Mbenza B, Lelo TM, Mbuilu PJ (2008). Rates and predictors of stroke-associated case fatality in black Central African patients. Cardiovasc. J. Afr. 19:72-6 | ||||
| M'Buyamba-Kabangu JR, Longo-Mbenza B, Tambwe MJ, Dikassa LN, Mbala-Mukendi M (1995). J-Shaped relationship between mortality and admission blood pressure in black patients with acute stroke. J. Hypertens. 13(12):1863-8. | ||||
|
Meng R, Ji X (2011). Plasma biomarker and stroke. Cerebrovasc. Dis. 32:406. Crossref |
||||
| Paul SL, Srikanth VK, Trift AG (2007). The large and growing burden of stroke. Curr. Drug Targets 8(7):7862793. | ||||
|
Prospective Studies Collaboration (1995). Cholesterol, diastolic blood pressure, and stroke: 13,000 strokes in 450,000 people in 45 prospective cohorts. Lancet 346:1647-53. Crossref |
||||
|
Rothwell PM (2001). The high cost of not funding stroke research: a comparison with heart disease and cancer. Lancet 357(9268):1612-6. Crossref |
||||
| Roy KS, Bandyopadhyay R, Paul R, Chakraborty S, Ray D, Mitra S, Mondal J, Biswas S (2014). Study on serum and urinary electrolyte changes in cerebrovascular accident. JIACM 15(2):91-5. | ||||
| Shadia I, Abbashar H, Amira S, Faroug Y, Ahmad BM, Osman G, Omer A, Mohamed S, Ahmed H, Mohmad MA, Esam MA (2011). Stroke in women (Sudanese experience). Am. J. Sci. Ind. Res. 2(2):157-60. | ||||
|
Sokrab TO, Sid-Ahmed FM, Idris MNA (2002). Acute Stroke Type, Risk Factors, and Early Outcome in a Developing Country: A View From Sudan Using a Hospital-Based Sample. J Stroke Cerebrovasc. Dis. 11(2): 63-5 Crossref |
||||
|
Strong K, Mathers C, Bonita R (2007). Preventing stroke: saving lives around the world. The Lancet Neurol. 6:182-7. Crossref |
||||
|
Sun H, Zou X, Liu L (2013). Epidemiological Factors of Stroke: A Survey of the Current Status in China. J. Stroke 15(2):109-14. Crossref |
||||
| The American Stroke Association (2006). Guidelines for Prevention of Stroke in Patients with stroke or Transient Ischemic Attack. Stroke 37:577-617. | ||||
|
Tran J, Mirzaei M, Anderson L, Leeder SR (2010). The epidemiology of stroke in the Middle East and North Africa. J. Neurol. Sci. 295:35-40. http://dx.doi.org/10.1016/j.jns.2010.05.016 |
||||
|
Wolf PA (2004). Epidemiology of stroke. In: Mohr JP, Choi DW, Grotta JC, Weir B, Wolf PA, eds: Stroke Pathophysiology, Diagnosis, and Management. Philadelphia: Churchill Livingstone pp 13-34. Crossref |
||||
| World Health Organization (1994). World Health Statistics Manual.1993. Geneva. Switzerland: World Health Organization. | ||||
|
Yano K, Reed DM, MacLean CJ (1989). Serum cholesterol and hemorrhagic stroke in the Honolulu Heart Program. Stroke 20:1460-5. Crossref |
||||
Copyright © 2024 Author(s) retain the copyright of this article.
This article is published under the terms of the Creative Commons Attribution License 4.0
